Characteristics:
| Type |
Vaccine |
| Purpose |
Complex vaccine |
| Packaging |
10ml
|
| Country of origin |
France |
Description:
Lyophilized tablets and injectable suspension
dogs
Qualitative and quantitative composition
Lyophilized tablets
Attenuated canine distemper …………….≥1040 CCID50
Attenuated canine adenovirus
(CAV2)………………………………………… ≥1015 CCID50
Attenuated canine parvovirus.......≥1047 CCID50
Attenuated parainfluenza virus
Type 2 ................................................ .................. ≥1047 CCID50
Excipient, qs................................................. ... 1 dose
Not activated
Leptospira canicola efficacy
Inactivated European Pharmacopoeia
Leptospira leterohaemorrhagiae according (*)
Auxiliary substance 1 dose of 1 ml
(*) The dose provides 80% protection in the hamster species (European Pharmacopoeia, monograph 447, efficacy according to the test)
Indications for use
In dogs:
Active immunization against plague, adenovirus, parvovirus, parainfluenza type 2 respiratory infections, and Leptospira canicola and Leptospira leterohaemorrhagiae.
Dosage, route(s) and method of administration for each species
Inject 1 ml of the dose subcutaneously according to the following schedule:
Primary vaccination
First injection: from 7 weeks of age.
Second injection: after 3 to 5 weeks of age, from 12 weeks of age.
Dose booster
annually.
Special warnings for use
Vaccinate only an absolutely healthy animal, properly examined not less than 10 days before vaccination.
Do not allow the dog to perform heavy physical activities until full immunity is achieved.
In case of serious risk of leptospirosis, a semester booster is recommended.
Adverse effects (frequency and seriousness)
Vaccination can cause a transient local reaction, as well as hyperthermia.
As with any vaccine, a hypersensitivity reaction may occur. This is rare and appropriate symptomatic treatment should be used.
Overdose (symptoms, emergency procedures, antidote), if necessary
Injection of an overdose of the vaccine can cause post-vaccination depression, as well as transient allergic reactions.
Immunological properties
Vaccine against distemper, adenovirus, parvovirus, parainfluenza type 2 respiratory infections (live) and Leptospira canicola and Leptospira leterohaemorrhagiae (inactivated) in dogs.
After administration, the vaccine causes immunity in dogs against distemper, adenovirus, parvovirus, parainfluenza type 2 respiratory infections (live) and Leptospira canicola and Leptospira leterohaemorrhagiae (inactivated).
Use during pregnancy and lactation
No side effects have been observed in female animals during pregnancy.
interaction
No information is available on the safety and efficacy of this vaccine when used in combination with other products.
incompatibility
Do not mix with other medical products.
Special precautions for the disposal of unused medical products or waste materials from such products
Empty containers and containers with unused product must be disinfected before disposal. Any unused product or waste material from such product should be disposed of in accordance with local requirements.
Special precautions for storage
Store at 2° to 8°C (refrigerated), protected from light.
Use immediately after dilution.
For animal treatment only.
